On the public citation graph

Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease

https://doi.org/10.1371/journal.pone.0142164
0 signed · 570 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/mds.23566openalex-snapshot
Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease
inferredcites →https://doi.org/10.1002/mds.23838openalex-snapshot
Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease
inferredcites →https://doi.org/10.1002/mds.25375openalex-snapshot
Pilot study of H2 therapy in Parkinson's disease: A randomized double‐blind placebo‐controlled trial
inferredcites →https://doi.org/10.1002/mds.25522openalex-snapshot
The role of small intestinal bacterial overgrowth in Parkinson's disease
inferredcites →https://doi.org/10.1002/mds.25736openalex-snapshot
Progression of intestinal permeability changes and alpha‐synuclein expression in a mouse model of Parkinson's disease
inferredcites →https://doi.org/10.1002/mds.25895openalex-snapshot
Peptidoglycan recognition protein genes and risk of Parkinson's disease
inferredcites →https://doi.org/10.1002/mds.26069openalex-snapshot
Gut microbiota are related to Parkinson's disease and clinical phenotype
inferredcites →https://doi.org/10.1002/mds.26307openalex-snapshot
Colonic bacterial composition in Parkinson's disease
inferredcites →https://doi.org/10.1007/s00415-002-1301-4openalex-snapshot
Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)
inferredcites →https://doi.org/10.1007/s10620-012-2526-4openalex-snapshot
Changes of the Intestinal Microbiota, Short Chain Fatty Acids, and Fecal pH in Patients with Colorectal Cancer
inferredcites →https://doi.org/10.1016/0165-1838(95)00002-fopenalex-snapshot
A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure
inferredcites →https://doi.org/10.1016/j.bbrc.2009.06.024openalex-snapshot
Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitis
inferredcites →https://doi.org/10.1016/j.freeradbiomed.2009.11.026openalex-snapshot
Oxidative damage in Parkinson disease: Measurement using accurate biomarkers
inferredcites →https://doi.org/10.1016/j.nbd.2012.09.007openalex-snapshot
Colonic inflammation in Parkinson's disease
inferredcites →https://doi.org/10.1016/j.neulet.2009.02.016openalex-snapshot
Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease
inferredcites →https://doi.org/10.1016/j.neuroscience.2014.10.028openalex-snapshot
Inflammation is genetically implicated in Parkinson’s disease
inferredcites →https://doi.org/10.1016/j.parkreldis.2009.08.007openalex-snapshot
A timeline for Parkinson's disease
inferredcites →https://doi.org/10.1016/j.parkreldis.2014.02.019openalex-snapshot
Small intestinal bacterial overgrowth in Parkinson's disease
inferredcites →https://doi.org/10.1016/j.parkreldis.2014.12.009openalex-snapshot
Helicobacter pylori infection is associated with worse severity of Parkinson's disease
inferredcites →https://doi.org/10.1016/s0026-0495(97)90136-0openalex-snapshot
Neuropeptide Y, galanin, and leptin release in obese women and in women with anorexia nervosa
inferredcites →https://doi.org/10.1016/s0197-4580(02)00065-9openalex-snapshot
Staging of brain pathology related to sporadic Parkinson’s disease
inferredcites →https://doi.org/10.1021/cr050196ropenalex-snapshot
Occurrence, Classification, and Biological Function of Hydrogenases: An Overview
inferredcites →https://doi.org/10.1038/nature12820openalex-snapshot
Diet rapidly and reproducibly alters the human gut microbiome
inferredcites →https://doi.org/10.1084/jem.164.3.777openalex-snapshot
Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.
inferredcites →https://doi.org/10.1093/brain/awt192openalex-snapshot
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
inferredcites →https://doi.org/10.1093/chemse/bjj037openalex-snapshot
Cross-Cultural Comparison of Data Using the Odor Stick Identification Test for Japanese (OSIT-J)
inferredcites →https://doi.org/10.1093/infdis/171.5.1250openalex-snapshot
Lipopolysaccharide Toxicity-Regulating Proteins in Bacteremia
inferredcites →https://doi.org/10.1097/01.wco.0000137531.76491.c2openalex-snapshot
Olfaction and Parkinson's syndromes: its role in differential diagnosis
inferredcites →https://doi.org/10.1111/j.1447-0594.2010.00585.xopenalex-snapshot
Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the Montreal Cognitive Assessment
inferredcites →https://doi.org/10.1111/j.1472-8206.2008.00616.xopenalex-snapshot
The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
inferredcites →https://doi.org/10.1111/j.1572-0241.2005.40312.xopenalex-snapshot
Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR
inferredcites →https://doi.org/10.1111/jre.12081openalex-snapshot
The role of lipopolysaccharide‐binding protein in innate immunity: a revisit and its relevance to oral/periodontal health
inferredcites →https://doi.org/10.1126/science.1241214openalex-snapshot
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
inferredcites →https://doi.org/10.1128/aem.01224-06openalex-snapshot
Sensitive Quantitative Detection of Commensal Bacteria by rRNA-Targeted Reverse Transcription-PCR
inferredcites →https://doi.org/10.1128/aem.01843-08openalex-snapshot
Establishment of an Analytical System for the Human Fecal Microbiota, Based on Reverse Transcription-Quantitative PCR Targeting of Multicopy rRNA Molecules
inferredcites →https://doi.org/10.1128/iai.69.11.6942-6950.2001openalex-snapshot
Dual Role of Lipopolysaccharide (LPS)-Binding Protein in Neutralization of LPS and Enhancement of LPS-Induced Activation of Mononuclear Cells
inferredcites →https://doi.org/10.1128/jcm.01724-09openalex-snapshot
Bacterial rRNA-Targeted Reverse Transcription-PCR Used To Identify Pathogens Responsible for Fever with Neutropenia
inferredcites →https://doi.org/10.1159/000103892openalex-snapshot
Small Intestinal Bacterial Overgrowth: Diagnosis and Treatment
inferredcites →https://doi.org/10.1172/jci109836openalex-snapshot
Diamine oxidase (histaminase). A circulating marker for rat intestinal mucosal maturation and integrity.
inferredcites →https://doi.org/10.1172/jci111738openalex-snapshot
Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study).
inferredcites →https://doi.org/10.1172/jci116106openalex-snapshot
Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs.
inferredcites →https://doi.org/10.1186/2045-9912-2-15openalex-snapshot
Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson’s disease in rats
inferredcites →https://doi.org/10.1212/01.wnl.0000221672.01272.baopenalex-snapshot
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations
inferredcites →https://doi.org/10.1212/01.wnl.0000247740.47667.03openalex-snapshot
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
inferredcites →https://doi.org/10.1212/wnl.57.3.456openalex-snapshot
Frequency of bowel movements and the future risk of Parkinson’s disease
inferredcites →https://doi.org/10.1371/journal.pone.0007247openalex-snapshot
Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease
inferredcites →https://doi.org/10.1371/journal.pone.0028032openalex-snapshot
Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease
inferredcites →https://doi.org/10.1515/cclm.1999.047openalex-snapshot
A Novel Acute-Phase Marker: Lipopolysaccharide Binding Protein (LBP)
inferredcites →https://doi.org/10.2337/dc13-2817openalex-snapshot
Gut Dysbiosis and Detection of “Live Gut Bacteria” in Blood of Japanese Patients With Type 2 Diabetes

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3918858openalex-extracted
inferred← citeshttps://doi.org/10.2139/ssrn.4113134openalex-extracted
Implications of Parkinson's Disease-Associated Alterations in the Oral and Gut Microbiome on Vitamin B 12 Biosynthesis and Levodopa Bioavailability
inferred← citeshttps://doi.org/10.1002/0471266949.bmc297openalex-snapshot
The Gut Microbiome
inferred← citeshttps://doi.org/10.1002/ana.24901openalex-snapshot
The gut microbiome in human neurological disease: A review
inferred← citeshttps://doi.org/10.1002/bjs.11654openalex-snapshot
Alteration in faecal bile acids, gut microbial composition and diversity after laparoscopic sleeve gastrectomy
inferred← citeshttps://doi.org/10.1002/brb3.3130openalex-snapshot
Parkinson's disease: Are gut microbes involved?
inferred← citeshttps://doi.org/10.1002/cph4.70137openalex-snapshot
The Brain‐Gut Axis in Parkinson's Disease Pathology
inferred← citeshttps://doi.org/10.1002/cphy.c230013openalex-snapshot
The Human Microbiome—A Physiologic Perspective
inferred← citeshttps://doi.org/10.1002/j.2040-4603.2024.tb00299.xopenalex-snapshot
The Human Microbiome—A Physiologic Perspective
inferred← citeshttps://doi.org/10.1002/mdc3.12840openalex-snapshot
Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain Axis
inferred← citeshttps://doi.org/10.1002/mds.26942openalex-snapshot
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome
inferred← citeshttps://doi.org/10.1002/mds.27099openalex-snapshot
The emerging science of precision medicine and pharmacogenomics for Parkinson's disease
inferred← citeshttps://doi.org/10.1002/mds.27105openalex-snapshot
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder
inferred← citeshttps://doi.org/10.1002/mds.27197openalex-snapshot
The prodromal microbiome
inferred← citeshttps://doi.org/10.1002/mds.27304openalex-snapshot
A controversy on the role of short‐chain fatty acids in the pathogenesis of Parkinson's disease
inferred← citeshttps://doi.org/10.1002/mds.27326openalex-snapshot
Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease
inferred← citeshttps://doi.org/10.1002/mds.27581openalex-snapshot
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
inferred← citeshttps://doi.org/10.1002/mds.28004openalex-snapshot
Implications of the Gut Microbiome in Parkinson's Disease
inferred← citeshttps://doi.org/10.1002/mds.28119openalex-snapshot
Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease
inferred← citeshttps://doi.org/10.1002/mds.29300openalex-snapshot
Integrated Multi‐Cohort Analysis of the Parkinson's Disease Gut Metagenome
inferred← citeshttps://doi.org/10.1002/mds.29432openalex-snapshot
The Endotoxin Hypothesis of Parkinson's Disease
inferred← citeshttps://doi.org/10.1002/med.21987openalex-snapshot
Communal interaction of glycation and gut microbes in diabetes mellitus, Alzheimer's disease, and Parkinson's disease pathogenesis
inferred← citeshttps://doi.org/10.1002/pro.4137openalex-snapshot
Identification of amyloidogenic proteins in the microbiomes of a rat Parkinson's disease model and wild‐type rats
inferred← citeshttps://doi.org/10.1007/978-3-030-81303-1_49-1openalex-snapshot
Markers of Bacterial Translocation in Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1007/978-3-030-91051-8_11openalex-snapshot
Neurodegenerative Diseases and the Gut Microbiota
inferred← citeshttps://doi.org/10.1007/978-3-031-08014-2_49openalex-snapshot
Markers of Bacterial Translocation in Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1007/978-3-031-14023-5_13openalex-snapshot
Gut Microbiota Changes and Parkinson’s Disease: What Do We Know, Which Avenues Ahead
inferred← citeshttps://doi.org/10.1007/978-3-031-47375-3_15openalex-snapshot
The Role of the Smallest Molecule Hydrogen Overcoming Ageing-Related Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-88769-7_13openalex-snapshot
Parasympathetic and Sympathetic Nervous System Dysfunction and Monitoring
inferred← citeshttps://doi.org/10.1007/978-3-319-90545-7_18openalex-snapshot
Microbiome and Diseases: Neurological Disorders
inferred← citeshttps://doi.org/10.1007/978-981-15-7157-2_4openalex-snapshot
Physiological Effects of the Hydrogen Molecules
inferred← citeshttps://doi.org/10.1007/978-981-19-0120-1_24openalex-snapshot
Sex Differences and Gut Microbiota Changes in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/978-981-19-3949-5_7-1openalex-snapshot
Molecular Changes and Gut-Related Biomarkers in Parkinson’s Disease for Early Detection
inferred← citeshttps://doi.org/10.1007/978-981-33-6586-5_5openalex-snapshot
Dopamine and Gastrointestinal Motility
inferred← citeshttps://doi.org/10.1007/978-981-99-1463-0_16openalex-snapshot
Dietary Modulation of the Nervous and Immune System: Role of Probiotics/Prebiotics/Synbiotics/Postbiotics
inferred← citeshttps://doi.org/10.1007/978-981-99-7557-0_7openalex-snapshot
Molecular Changes and Gut-Related Biomarkers in Parkinson’s Disease for Early Detection
inferred← citeshttps://doi.org/10.1007/978-981-99-8803-7_13openalex-snapshot
Role of Gut Brain and Gut Oral Axis in Progression of Parkinson’s Disease with Special Focus on Gut Microbes
inferred← citeshttps://doi.org/10.1007/s00005-019-00561-6openalex-snapshot
Gut Microbiota in Neurological Disorders
inferred← citeshttps://doi.org/10.1007/s00115-018-0601-6openalex-snapshot
Das Darmmikrobiom bei der Parkinson-Krankheit
inferred← citeshttps://doi.org/10.1007/s00115-020-01011-xopenalex-snapshot
Die Rolle des Darmmikrobioms beim idiopathischen Parkinson-Syndrom
inferred← citeshttps://doi.org/10.1007/s00401-017-1777-8openalex-snapshot
Does Parkinson’s disease start in the gut?
inferred← citeshttps://doi.org/10.1007/s00401-018-1856-5openalex-snapshot
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?
inferred← citeshttps://doi.org/10.1007/s00415-017-8639-0openalex-snapshot
Nutritional habits, risk, and progression of Parkinson disease
inferred← citeshttps://doi.org/10.1007/s00415-019-09320-1openalex-snapshot
Parkinson’s disease and the gastrointestinal microbiome
inferred← citeshttps://doi.org/10.1007/s00415-022-11461-9openalex-snapshot
Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases
inferred← citeshttps://doi.org/10.1007/s10072-025-08114-wopenalex-snapshot
The interrelationship between intestinal immune cells and enteric α-synuclein in the progression of Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s10096-020-03944-2openalex-snapshot
Is Porphyromonas gingivalis involved in Parkinson’s disease?
inferred← citeshttps://doi.org/10.1007/s10143-021-01516-2openalex-snapshot
Does modern research validate the ancient wisdom of gut flora and brain connection? A literature review of gut dysbiosis in neurological and neurosurgical disorders over the last decade
inferred← citeshttps://doi.org/10.1007/s10571-021-01066-7openalex-snapshot
The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s10571-023-01319-7openalex-snapshot
Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent
inferred← citeshttps://doi.org/10.1007/s10620-018-5122-4openalex-snapshot
Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors
inferred← citeshttps://doi.org/10.1007/s10787-026-02152-2openalex-snapshot
Prebiotics attenuate depressive-like behavior, neuroinflammation and synaptic plasticity in Parkinson’s disease by modulating butyrate-producing gut bacteria
inferred← citeshttps://doi.org/10.1007/s11010-025-05271-6openalex-snapshot
Gut microbiota and microRNAs as biomarkers in Parkinson’s disease: early identification, diagnostic and potential treatments
inferred← citeshttps://doi.org/10.1007/s11011-018-0239-xopenalex-snapshot
Impaired tissue barriers as potential therapeutic targets for Parkinson’s disease and amyotrophic lateral sclerosis
inferred← citeshttps://doi.org/10.1007/s11011-021-00808-2openalex-snapshot
Gut brain axis: an insight into microbiota role in Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s11064-020-03187-9openalex-snapshot
Is Gut Dysbiosis an Epicenter of Parkinson’s Disease?
inferred← citeshttps://doi.org/10.1007/s12031-026-02530-zopenalex-snapshot
Unveiling the Gut-Brain Axis: Fusobacteriaceae Promotes Parkinson’s Disease Development via CA9 Suppression-Induced Ferroptosis
inferred← citeshttps://doi.org/10.1007/s12035-024-04151-2openalex-snapshot
The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s12035-024-04156-xopenalex-snapshot
The Impact of Prevotella on Neurobiology in Aging: Deciphering Dendritic Cell Activity and Inflammatory Dynamics
inferred← citeshttps://doi.org/10.1007/s12035-025-05598-7openalex-snapshot
Alterations of Gut Microbiota and Microbial Metabolites in Parkinson’s Disease: A Systematic Review
inferred← citeshttps://doi.org/10.1007/s12223-022-00977-2openalex-snapshot
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s12602-024-10274-8openalex-snapshot
Potential Applications of Blautia wexlerae in the Regulation of Host Metabolism
inferred← citeshttps://doi.org/10.1007/s12640-019-0010-zopenalex-snapshot
Local Gastrointestinal Injury Exacerbates Inflammation and Dopaminergic Cell Death in Parkinsonian Mice
inferred← citeshttps://doi.org/10.1007/s12640-022-00487-6openalex-snapshot
Prenatal Isoflurane Exposure Induces Developmental Neurotoxicity in Rats: the Role of Gut Microbiota
inferred← citeshttps://doi.org/10.1007/s13311-017-0598-8openalex-snapshot
Microbiota Signaling Pathways that Influence Neurologic Disease
inferred← citeshttps://doi.org/10.1007/s13311-020-00942-2openalex-snapshot
Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond
inferred← citeshttps://doi.org/10.1007/s13670-018-0240-6openalex-snapshot
The Microbiome in Neurodegenerative Disease
inferred← citeshttps://doi.org/10.1007/s13760-023-02195-0openalex-snapshot
Altered gut microbiota in patients with idiopathic Parkinson’s disease: an age–sex matched case–control study
inferred← citeshttps://doi.org/10.1007/s40473-017-0129-2openalex-snapshot
Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s40572-018-0186-zopenalex-snapshot
Environmental Exposures and Neuropsychiatric Disorders: What Role Does the Gut–Immune–Brain Axis Play?
inferred← citeshttps://doi.org/10.1007/s42399-026-02402-yopenalex-snapshot
Decoding the Gut Microbiome in Neuromuscular Diseases: a Review of Fundamental Mechanisms and Condition-Specific Evidence
inferred← citeshttps://doi.org/10.1007/s43440-025-00799-2openalex-snapshot
The ketogenic diet in Parkinson’s disease: a potential therapeutic strategy
inferred← citeshttps://doi.org/10.1007/s44368-025-00016-5openalex-snapshot
The compounding roles of gut-immune-brain axis and COVID19 in manifestation of idiopathic Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.62181-5openalex-snapshot
Gut Microbiota and Aging: Targets and Anti-aging Interventions
inferred← citeshttps://doi.org/10.1016/b978-0-12-814649-1.00012-0openalex-snapshot
Gut Microbiota in Brain Development and Disorders of the CNS: Therapeutic Strategies Involving Dietary Modification, Pro- and Prebiotic Intervention, and Fecal Microbiota Transplantation (FMT) Therapy
inferred← citeshttps://doi.org/10.1016/b978-0-12-819265-8.00012-7openalex-snapshot
Microbiome Based Diseases Diagnostics
inferred← citeshttps://doi.org/10.1016/b978-0-12-819265-8.00041-3openalex-snapshot
Gut Dysbiosis and Neurological Disorders—An Eclectic Perspective
inferred← citeshttps://doi.org/10.1016/b978-0-12-821039-0.00008-3openalex-snapshot
The contribution of gut microbiota in the pathogenesis of Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-85555-6.00006-0openalex-snapshot
Disease mechanisms as subtypes: Microbiome
inferred← citeshttps://doi.org/10.1016/b978-0-323-89835-5.00031-4openalex-snapshot
Vitamin D and Parkinson's disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-90052-2.00034-2openalex-snapshot
Prebiotics and probiotics and Parkinson's disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-91313-3.00003-9openalex-snapshot
Interplay of alpha-synuclein pathology and gut microbiome in Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-91313-3.00016-7openalex-snapshot
Human microbiome and neurological disorders
inferred← citeshttps://doi.org/10.1016/b978-0-323-95735-9.00047-4openalex-snapshot
Probiotics protect against progressive deterioration of motor functions and Parkinson's disease
inferred← citeshttps://doi.org/10.1016/b978-0-443-15435-5.00010-4openalex-snapshot
Human microbiome and neuro-developmental disorders
inferred← citeshttps://doi.org/10.1016/b978-0-443-21680-0.00013-4openalex-snapshot
Role of microbiome gut-brain axis in brain disorders
inferred← citeshttps://doi.org/10.1016/b978-0-443-28822-7.00016-7openalex-snapshot
The impact of microbiological infections on neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/b978-0-443-36372-6.00014-8openalex-snapshot
Therapeutic potential of phytochemicals and role of gut microbiota in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/b978-0-443-40306-4.00004-1openalex-snapshot
Interrelationship between intestinal immune cells and barrier function in the development of neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/bs.irn.2022.07.006openalex-snapshot
Microbiome influences on neuro-immune interactions in neurodegenerative disease
inferred← citeshttps://doi.org/10.1016/bs.irn.2022.07.007openalex-snapshot
The many genomes of Parkinson's disease
inferred← citeshttps://doi.org/10.1016/bs.irn.2025.03.004openalex-snapshot
Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson’s disease (PD)
inferred← citeshttps://doi.org/10.1016/bs.pbr.2020.01.004openalex-snapshot
The gut microbiome in Parkinson's disease: A culprit or a bystander?
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2022.08.004openalex-snapshot
Human gut microbiota and Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.ajp.2024.104068openalex-snapshot
Microbiota-brain axis: Exploring the role of gut microbiota in psychiatric disorders - A comprehensive review
inferred← citeshttps://doi.org/10.1016/j.applanim.2022.105569openalex-snapshot
Effects of Lactiplantibacillus plantarum PS128 on alleviating canine aggression and separation anxiety
inferred← citeshttps://doi.org/10.1016/j.arr.2018.04.004openalex-snapshot
Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1016/j.arr.2021.101347openalex-snapshot
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.arr.2021.101396openalex-snapshot
The neuromicrobiology of Parkinson’s disease: A unifying theory
inferred← citeshttps://doi.org/10.1016/j.arr.2022.101759openalex-snapshot
Emerging insights between gut microbiome dysbiosis and Parkinson’s disease: Pathogenic and clinical relevance
inferred← citeshttps://doi.org/10.1016/j.arr.2023.102171openalex-snapshot
Does gut brain axis has an impact on Parkinson’s disease (PD)?
inferred← citeshttps://doi.org/10.1016/j.arr.2024.102504openalex-snapshot
Ageing, proteostasis, and the gut: Insights into neurological health and disease
inferred← citeshttps://doi.org/10.1016/j.arr.2025.102894openalex-snapshot
The role of the gut microbiota in neuropsychiatric disorders and therapy
inferred← citeshttps://doi.org/10.1016/j.bbadis.2025.167862openalex-snapshot
Parkinson's disease and gut microbiota metabolites: The dual impact of vitamins and functional amyloids
inferred← citeshttps://doi.org/10.1016/j.bbi.2017.06.017openalex-snapshot
Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.bbi.2018.02.016openalex-snapshot
Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.bbi.2019.07.019openalex-snapshot
Monocyte mobilisation, microbiota & mental illness
inferred← citeshttps://doi.org/10.1016/j.bbi.2020.01.018openalex-snapshot
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.bbi.2020.07.036openalex-snapshot
Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.bbi.2026.106840openalex-snapshot
Pramipexole promotes CD8+ regulatory T cell-dependent neuroprotection in Parkinson’s disease patients
inferred← citeshttps://doi.org/10.1016/j.bbih.2026.101206openalex-snapshot
Serum LBP and zonulin levels with brain MRS findings and gastrointestinal symptoms in schizophrenia and health
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112343openalex-snapshot
Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.114816openalex-snapshot
Probiotics as functional foods: How probiotics can alleviate the symptoms of neurological disabilities
inferred← citeshttps://doi.org/10.1016/j.bpg.2017.09.009openalex-snapshot
Lifestyle alters GUT-bacteria function: Linking immune response and host
inferred← citeshttps://doi.org/10.1016/j.brainres.2017.04.019openalex-snapshot
Gut microbiota in Parkinson disease in a northern German cohort
inferred← citeshttps://doi.org/10.1016/j.brainres.2018.01.010openalex-snapshot
Parkinson’s disease from the gut
inferred← citeshttps://doi.org/10.1016/j.brainres.2021.147609openalex-snapshot
The link between the gut microbiota and Parkinson’s Disease: A systematic mechanism review with focus on α-synuclein transport
inferred← citeshttps://doi.org/10.1016/j.brainres.2024.148757openalex-snapshot
The association between alpha diversity of gut microbiota, neuroimaging markers and cognitive function in cerebral small vessel disease
inferred← citeshttps://doi.org/10.1016/j.brainres.2024.149032openalex-snapshot
Intestinal flora influences the progression of subarachnoid hemorrhage by affecting peripheral and central inflammatory pathways
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2019.07.027openalex-snapshot
Lactobacillus plantarum PS128 ameliorates 2,5-Dimethoxy-4-iodoamphetamine-induced tic-like behaviors via its influences on the microbiota–gut-brain-axis
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2021.04.010openalex-snapshot
Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: Avenues for therapeutic intervention
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2022.02.015openalex-snapshot
Brain-gut-microbiota axis in Parkinson’s disease: A historical review and future perspective
inferred← citeshttps://doi.org/10.1016/j.cbi.2021.109452openalex-snapshot
Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice
inferred← citeshttps://doi.org/10.1016/j.cell.2016.10.027openalex-snapshot
The Central Nervous System and the Gut Microbiome
inferred← citeshttps://doi.org/10.1016/j.cell.2016.11.018openalex-snapshot
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
inferred← citeshttps://doi.org/10.1016/j.chom.2020.06.008openalex-snapshot
The Microbiome as a Modifier of Neurodegenerative Disease Risk
inferred← citeshttps://doi.org/10.1016/j.crmicr.2025.100471openalex-snapshot
Gut microbiome species Levilactobacillus brevis regulates reproductive fitness in C. elegans
inferred← citeshttps://doi.org/10.1016/j.csbj.2022.02.024openalex-snapshot
Analysis methods for the gut microbiome in neuropsychiatric and neurodegenerative disorders
inferred← citeshttps://doi.org/10.1016/j.ebiom.2019.05.064openalex-snapshot
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
inferred← citeshttps://doi.org/10.1016/j.ebiom.2025.105796openalex-snapshot
How leaky is the gut in Parkinson’s disease?
inferred← citeshttps://doi.org/10.1016/j.eng.2019.07.026openalex-snapshot
Targeting Gut Microbiota Dysbiosis: Potential Intervention Strategies for Neurological Disorders
inferred← citeshttps://doi.org/10.1016/j.exger.2024.112444openalex-snapshot
Association between increased and decreased gut microbiota abundance and Parkinson's disease: A systematic review and subgroup meta-analysis
inferred← citeshttps://doi.org/10.1016/j.exger.2024.112497openalex-snapshot
Influence of human gut microbiome on the healthy and the neurodegenerative aging
inferred← citeshttps://doi.org/10.1016/j.fbio.2023.103548openalex-snapshot
Effect of Lycium ruthenicum and Lycium barbarum intake on Parkinson based on microbiology and metabonomics: A randomized pilot trial
inferred← citeshttps://doi.org/10.1016/j.gpb.2021.08.009openalex-snapshot
Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2020.09.056openalex-snapshot
Genetic variants of TAS2R38 bitter taste receptor associate with distinct gut microbiota traits in Parkinson's disease: A pilot study
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.102088openalex-snapshot
Mechanistic insights into accelerated α-synuclein aggregation mediated by human microbiome-associated functional amyloids
inferred← citeshttps://doi.org/10.1016/j.jff.2023.105915openalex-snapshot
Gut-brain axis and Alzheimer's disease: Therapeutic interventions and strategies
inferred← citeshttps://doi.org/10.1016/j.jnutbio.2018.04.004openalex-snapshot
Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease
inferred← citeshttps://doi.org/10.1016/j.jpsychires.2018.01.013openalex-snapshot
Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder
inferred← citeshttps://doi.org/10.1016/j.lfs.2024.122748openalex-snapshot
Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights
inferred← citeshttps://doi.org/10.1016/j.livres.2020.03.002openalex-snapshot
Intestinal barrier function and metabolic/liver diseases
inferred← citeshttps://doi.org/10.1016/j.livres.2021.07.002openalex-snapshot
Bile acid receptors and signaling crosstalk in the liver, gut and brain
inferred← citeshttps://doi.org/10.1016/j.mad.2023.111875openalex-snapshot
Exploring the interplay between metabolomics and genetics in Parkinson's disease: Insights from ongoing research and future avenues
inferred← citeshttps://doi.org/10.1016/j.mehy.2019.109436openalex-snapshot
Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.micpath.2020.104675openalex-snapshot
Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.micpath.2025.107905openalex-snapshot
The relationship between increased levels of microbiota-derived lipopolysaccharide in obesity and the pathophysiology of neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.microb.2026.100719openalex-snapshot
The ‘gut feeling’: Connecting neurodegenerative diseases and gut microbiota
inferred← citeshttps://doi.org/10.1016/j.nbd.2019.02.011openalex-snapshot
Manipulation of microbiota reveals altered callosal myelination and white matter plasticity in a model of Huntington disease
inferred← citeshttps://doi.org/10.1016/j.nbd.2019.03.014openalex-snapshot
The impact of indigenous microbes on Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.nbd.2020.104744openalex-snapshot
Reprint of: Manipulation of microbiota reveals altered callosal myelination and white matter plasticity in a model of Huntington disease
inferred← citeshttps://doi.org/10.1016/j.nbd.2020.105027openalex-snapshot
Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series
inferred← citeshttps://doi.org/10.1016/j.nbd.2022.105744openalex-snapshot
Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.nbd.2022.105806openalex-snapshot
The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2020.02.003openalex-snapshot
Gut microbiota differences between healthy older adults and individuals with Parkinson’s disease: A systematic review
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2021.02.044openalex-snapshot
Mining microbes for mental health: Determining the role of microbial metabolic pathways in human brain health and disease
inferred← citeshttps://doi.org/10.1016/j.neuint.2018.08.005openalex-snapshot
Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.neuint.2024.105803openalex-snapshot
Modulating the biosynthesis and TLR4-interaction of lipopolysaccharide as an approach to counter gut dysbiosis and Parkinson's disease: Role of phyto-compounds
inferred← citeshttps://doi.org/10.1016/j.neuint.2026.106211openalex-snapshot
Non-pharmacological interventions modulating immune response in Parkinson's disease: where do we stand for future preventive approaches
inferred← citeshttps://doi.org/10.1016/j.neulet.2018.12.021openalex-snapshot
Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.neures.2021.01.001openalex-snapshot
Unravelling the role of gut microbiota in Parkinson’s disease progression: Pathogenic and therapeutic implications
inferred← citeshttps://doi.org/10.1016/j.neuro.2018.02.013openalex-snapshot
Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2016.08.019openalex-snapshot
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
inferred← citeshttps://doi.org/10.1016/j.neurol.2022.12.010openalex-snapshot
Oral and intestinal dysbiosis in Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.neurop.2025.100206openalex-snapshot
Bridging the gap: Unveiling the gut's influence on Parkinson's disease through probiotic interventions
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2020.02.030openalex-snapshot
The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1016/j.nrl.2019.03.017openalex-snapshot
Papel de la microbiota intestinal en el desarrollo de diferentes enfermedades neurológicas
inferred← citeshttps://doi.org/10.1016/j.nrleng.2019.03.026openalex-snapshot
Role of the gut microbiota in the development of various neurological diseases
inferred← citeshttps://doi.org/10.1016/j.nutres.2022.07.007openalex-snapshot
Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders
inferred← citeshttps://doi.org/10.1016/j.nutres.2024.11.013openalex-snapshot
A low-dose prebiotic fiber supplement reduces lipopolysaccharide-binding protein concentrations in a subgroup of young, healthy adults consuming low-fiber diets
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2018.09.032openalex-snapshot
A punch in the gut – Intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2018.11.014openalex-snapshot
Can the gut be the missing piece in uncovering PD pathogenesis?
inferred← citeshttps://doi.org/10.1016/j.phrs.2020.104677openalex-snapshot
Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide
inferred← citeshttps://doi.org/10.1016/j.phrs.2021.105840openalex-snapshot
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
inferred← citeshttps://doi.org/10.1016/j.phrs.2023.106787openalex-snapshot
Antiparkinsonian effects of polyphenols: A narrative review with a focus on the modulation of the gut-brain axis
inferred← citeshttps://doi.org/10.1016/j.redox.2018.05.007openalex-snapshot
Neuron-specific regulation of superoxide dismutase amid pathogen-induced gut dysbiosis
inferred← citeshttps://doi.org/10.1016/j.rvsc.2024.105521openalex-snapshot
Evaluation of serum and fecal parameters in cats with low-grade intestinal T-cell lymphoma (LGITCL)
inferred← citeshttps://doi.org/10.1016/j.taap.2022.116176openalex-snapshot
Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: Relevance to idiopathic Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.tem.2021.11.005openalex-snapshot
Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.tifs.2021.07.004openalex-snapshot
Dietary patterns affect Parkinson's disease via the microbiota-gut-brain axis
inferred← citeshttps://doi.org/10.1016/j.tim.2022.01.004openalex-snapshot
Microbes and Parkinson’s disease: from associations to mechanisms
inferred← citeshttps://doi.org/10.1016/j.toxlet.2021.12.003openalex-snapshot
Environmental factors in Parkinson’s disease: New insights into the molecular mechanisms
inferred← citeshttps://doi.org/10.1016/s1474-4422(19)30356-4openalex-snapshot
The gut microbiome in neurological disorders
inferred← citeshttps://doi.org/10.1016/s2468-1253(22)00241-2openalex-snapshot
The intestinal barrier in disorders of the central nervous system
inferred← citeshttps://doi.org/10.1017/neu.2025.16openalex-snapshot
Escitalopram alters tryptophan metabolism, plasma lipopolysaccharide, and the inferred functional potential of the gut microbiome in deer mice showing compulsive-like rigidity
inferred← citeshttps://doi.org/10.1038/s41398-025-03504-2openalex-snapshot
Bidirectional crosstalk between the gut microbiota and cellular compartments of brain: Implications for neurodevelopmental and neuropsychiatric disorders
inferred← citeshttps://doi.org/10.1038/s41467-023-36497-xopenalex-snapshot
An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson’s disease participants
inferred← citeshttps://doi.org/10.1038/s41531-016-0002-0openalex-snapshot
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
inferred← citeshttps://doi.org/10.1038/s41531-020-00145-8openalex-snapshot
Irritable bowel syndrome and Parkinson’s disease risk: register-based studies
inferred← citeshttps://doi.org/10.1038/s41531-020-0112-6openalex-snapshot
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
inferred← citeshttps://doi.org/10.1038/s41531-021-00170-1openalex-snapshot
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
inferred← citeshttps://doi.org/10.1038/s41531-022-00328-5openalex-snapshot
Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease
inferred← citeshttps://doi.org/10.1038/s41531-022-00428-2openalex-snapshot
Gut microbiota in dementia with Lewy bodies
inferred← citeshttps://doi.org/10.1038/s41531-023-00511-2openalex-snapshot
Gastrointestinal disorders in Parkinson’s disease and other Lewy body diseases
inferred← citeshttps://doi.org/10.1038/s41531-024-00724-zopenalex-snapshot
Meta-analysis of shotgun sequencing of gut microbiota in Parkinson’s disease
inferred← citeshttps://doi.org/10.1038/s41531-024-00816-wopenalex-snapshot
α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice
inferred← citeshttps://doi.org/10.1038/s41531-025-01236-0openalex-snapshot
Gut bacteria composition in animal models of Parkinson’s disease: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1038/s41579-020-00460-0openalex-snapshot
The gut microbiota–brain axis in behaviour and brain disorders
inferred← citeshttps://doi.org/10.1038/s41583-021-00542-9openalex-snapshot
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
inferred← citeshttps://doi.org/10.1038/s41598-017-10711-5openalex-snapshot
Evolution of gut Bifidobacterium population in healthy Japanese infants over the first three years of life: a quantitative assessment
showing the first 200 of 521
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.